60B is half of what pharma companies allegedly sent back to their shareholders from insulin price hikes. There's better places to direct anger towards overspent

60B is half of what pharma companies allegedly sent back to their shareholders from insulin price hikes. There's better places to direct anger towards overspent money IMHO. At least some people are happy with their Quest 2/3. > Novo Nordisk and Sanofi have seen huge gains as the list price of insulin has grown. The companies have collectively distributed a total of $122 billion to shareholders in the form of share buybacks and cash dividends over the period 2009-2018. https://www.ineteconomics.org/perspectives/blog/who-benefits-when-the-price-of-insulin-soars https://www.ineteconomics.org/perspectives/blog/who-benefits...